Chinese instructions for dabrafenib

1. Indications:

Dabrafenib is a BRAFkinase inhibitor, suitable for the treatment of BRAF V600 gene mutation-positive malignant melanoma (MM). The drug may also be used in patients with non-small cell lung cancer (NSCLC) when the tumors express the BRAF V600E gene mutation.

2. Mechanism of action:

Dabrafenib selectively inhibits the activity of BRAFkinase and blocks the abnormal activation of the BRAF/MEK/ERK signaling pathway, thereby inhibiting the growth and division of cancer cells. This mechanism helps slow down the progression and spread of tumors.

3. Pharmacology:

Dabrafenib is rapidly metabolized after absorption, mainly through liver metabolism, forming active metabolites. It has a short half-life in the body and needs to be taken regularly to maintain therapeutic effects. The metabolic pathway and excretion mode of the drug in the body have a certain impact on individual differences among patients. Therefore, the patient's bioavailability needs to be closely monitored during medication.

4. Dosage and usage:

Based on the patient's weight, physical condition, and specific illness, the doctor will determine the appropriate dose and usage of dabrafenib. Usually, patients are advised to take a certain dose orally every day for continuous use. During treatment, doctors may make adjustments based on patient response and drug tolerance.

5. Side effects:

Common side effects of dabrafenib include but are not limited to: fever, fatigue, headache, skin lesions, etc. In some cases, serious side effects may occur, such as hypertension, cardiac arrhythmia, retinal inflammation, etc. Patients should pay close attention to their physical condition during medication and report any abnormal reactions in a timely manner.

6. Warnings and Precautions:

Patients need to pay special attention to the following when using dabrafenib:

Heart monitoring: Medications may cause heart problems, and patients need to undergo regular electrocardiograms.

Retinal toxicity: May cause visual impairment, regular eye exams are necessary.

Fever reaction: Fever may occur during drug use and needs to be reported to the doctor in time.

7. Contraindications:

Dabrafenib is contraindicated in the following circumstances:

Patients who are allergic to drug ingredients.

Pregnant and breastfeeding women, unless the potential benefits of treatment outweigh the potential risks.

8. Drug interactions:

Dabrafenib may interact with some drugs, including but not limited to inhibitors and inducers of the CYP3A4 enzyme. Patients need to inform their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements, before taking them.

9. Drugs for special groups:

Certain populations, such as elderly patients, patients with impaired liver function, etc., may need to adjust the dose. Pregnant women should avoid use except under the explicit guidance of a physician and when the potential therapeutic benefits outweigh the potential risks.

10. Listing and price situation:

Dabrafenib is already on the market in China and has been included in medical insurance. Patients can buy it domestically. The price is about 10,000 yuan in China. The price is still relatively expensive. Please consult the local hospital pharmacy for specific prices. Dabrafenib, which is relatively cheap abroad, is mainly a generic drug, mainly a Laotian generic drug. The price is about two to three thousand yuan, which is much cheaper than domestic drugs. The ingredients of foreign generic drugs and domestic original drugs are basically the same.

When using dabrafenib, patients should undergo regular physical examinations, laboratory tests and other related examinations to ensure optimal treatment effects and reduce potential adverse reactions. Therefore, before using this drug, patients should carefully read the drug instructions provided by the doctor and take the medication according to the doctor's advice and supervision.